Literature DB >> 21855164

ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.

Sanjay Popat1, David Gonzalez, Toon Min, John Swansbury, Melissa Dainton, James G Croud, Alexandra J Rice, Andrew G Nicholson.   

Abstract

BACKGROUND: ALK rearrangement is particularly observed in signet-ring sub-type adenocarcinoma. Since fluorescence in situ hybridization (FISH) is not suitable for mass screening, we aimed to characterize the predictive utility of tumour morphology and ALK immunoreactivity to identify ALK rearrangement, in a primary lung adenocarcinoma dataset enriched for signet-ring morphology, compared with that of other morphology.
METHODS: 7 adenocarcinomas from diagnostic archives reported with signet-ring morphology were assessed and compared with 11 adenocarcinomas without signet-ring features over the same time period. Growth patterns were reviewed, ALK expression was assessed by standard immunohistochemistry using ALK1 clone and Envision detection (Dako), and ALK rearrangement was assessed by FISH (Abbott Molecular). Associations between groups and predictive utility of tumour morphology and ALK expression using FISH as gold standard were calculated.
RESULTS: 2 excision lung biopsy cases with pure (100%) signet-ring morphology and solid patterns demonstrated diffuse moderate cytoplasmic ALK immunoreactivity (2+) and harboured ALK rearrangements (p=0.007), unlike 5 mixed-signet-ring and 11 non-signet-ring adenocarcinomas, which showed negative or 1+ immunoreactivity; and did not harbour ALK rearrangements (p>0.1). ALK expression was not associated with ALK copy number. 6 of 7 cases with signet ring morphology stained for TTF-1. Pure signet-ring morphology and moderate ALK expression were both associated with ALK rearranged tumours.
CONCLUSION: ALK rearrangement is strongly associated with ALK immunoreactivity, and was seen only in tumours with pure signet-ring morphology and solid growth pattern. Tumour morphology, growth pattern and ALK immunoreactivity appear to be good indicators of ALK rearrangement, with TTF-1 positivity aiding in proving primary pulmonary origin.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855164     DOI: 10.1016/j.lungcan.2011.07.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  16 in total

Review 1.  Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement.

Authors:  Hyojin Kim; Jin-Haeng Chung
Journal:  Transl Lung Cancer Res       Date:  2015-04

2.  Treating Anaplastic Lymphoma Kinase-Positive Lung Cancer in the Weeks After the US Food and Drug Administration Approval of Crizotinib.

Authors:  Nathan A Pennell
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

3.  Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.

Authors:  Olatunji B Alese; Bassel F El-Rayes; Gabriel Sica; Guojing Zhang; Dianne Alexis; Francisco G La Rosa; Marileila Varella-Garcia; Zhengjia Chen; Michael R Rossi; Nazim V Adsay; Fadlo R Khuri; Taofeek K Owonikoko
Journal:  Ther Adv Med Oncol       Date:  2015-03       Impact factor: 8.168

4.  Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors.

Authors:  Jassem M Bastaki; Bibianna M Purgina; Sanja Dacic; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2014-01-21

5.  CRISPR-barcoding in non small cell lung cancer: from intratumor genetic heterogeneity modeling to cancer therapy application.

Authors:  Federica Zito Marino; Marina Accardo; Renato Franco
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features.

Authors:  Luciana Possidente; Matteo Landriscina; Giuseppe Patitucci; Ludovica Borgia; Vittoria Lalinga; Giulia Vita
Journal:  Med Oncol       Date:  2017-03-31       Impact factor: 3.064

Review 7.  Diagnosis and Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.

Authors:  Kathryn C Arbour; Gregory J Riely
Journal:  Hematol Oncol Clin North Am       Date:  2017-02       Impact factor: 3.722

Review 8.  Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.

Authors:  Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2017-10

9.  Ocular metastasis of lung adenocarcinoma with ELM4-ALK translocation: A case report with a review of the literature.

Authors:  Kailun Jiang; Seymour Brownstein; Harmanjatinder S Sekhon; Scott A Laurie; Kay Lam; Steven Gilberg; William Britton
Journal:  Saudi J Ophthalmol       Date:  2013-07

10.  Prognostic significance of anaplastic lymphoma kinase rearrangement in patients with completely resected lung adenocarcinoma.

Authors:  Yinglei Liu; Xiangyun Ye; Yongfeng Yu; Shun Lu
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.